Latest News

Data Shows Subcutaneous Rituximab Similar to IV in Non-Hodgkin Lymphoma
Data Shows Subcutaneous Rituximab Similar to IV in Non-Hodgkin Lymphoma

September 9th 2024

Subcutaneous and intravenous forms of rituximab showed similar efficacy in patients with non-Hodgkin lymphoma.

NCCN Guidelines Add Denileukin Diftitox for CTCL Treatment
NCCN Guidelines Add Denileukin Diftitox for CTCL Treatment

September 9th 2024

Clinically Meaningful Efficacy Observed in R/R PTCL With Valemetostat
Clinically Meaningful Efficacy Observed in R/R PTCL With Valemetostat

September 9th 2024

Greater Use of Histologic-Based Therapy, Imaging, and MRD Testing Improves Outcomes in PTCL
Greater Use of Histologic-Based Therapy, Imaging, and MRD Testing Improves Outcomes in PTCL

September 7th 2024

Improved Sensitivity Leads to Expanded MRD Use in Lymphoma
Improved Sensitivity Leads to Expanded MRD Use in Lymphoma

September 5th 2024

Video Series
Video Interviews
Podcasts

More News